Senicapoc
CAS No. 289656-45-7
Senicapoc( ICA-17043 )
Catalog No. M13889 CAS No. 289656-45-7
A potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 49 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 99 | In Stock |
|
| 100MG | 132 | In Stock |
|
| 200MG | 197 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSenicapoc
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM).
-
DescriptionA potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM); shows greater potency and selectivity than Clotrimazole; increases RBC K(+) content and hematocrit (Hct), decreases corpuscular hemoglobin concentration (MCHC) in a transgenic mouse model of sickle cell disease (SAD); orally active.Other Indication Phase 3 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsICA-17043
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorGardoschannel
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number289656-45-7
-
Formula Weight323.336
-
Molecular FormulaC20H15F2NO
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N
-
Chemical NameBenzeneacetamide, 4-fluoro-.alpha.-(4-fluorophenyl)-.alpha.-phenyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Retigabine dihydroch...
Retigabine dihydrochloride is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients.?The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.In differentiated PC12 cells, retigabine enhanced a linopirdine-sensitive current.?
-
Linopirdine
Linopirdine (DUP-996;Linopirine) is a potent Kv7 (KCNQ) voltage-gated potassium channels blcoker; blocks KV7.1+7.3 (KCNQ2+3)/M-currents (IC50=4-7 uM) and KV7.1 (KCNQ1) homomeric channels (IC50=8.9 uM).
-
NS-3623
A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
Cart
sales@molnova.com